netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 11: Eye - Full Chapter
11.99.99.99  Expand sub section  Miscellaneous
11.99.99.99  Expand sub section  Antifungals
11.99.99.99  Expand sub section  Cytotoxics / wound healing modulators
11.99.99.99  Expand sub section  Fibrinolytic drugs
11.99.99.99  Expand sub section  Glues - ocular to top
11.99.99.99  Expand sub section  Immunosuppressants
11.99.99.99  Expand sub section  Treatment of burns
11.99.99.99  Expand sub section  Visco-elastics
11.99.99.99  Expand sub section  Other
Adrenaline eye drop
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for diagnostic, testing for pupils, and to control bleeding during surgery, or prevent rapid loss of sub-conjunctival injections into systemic circulation (0.01% & 0.1%)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Alteplase 25mcg/0.1ml intravitreal injection
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted for eye procedures
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Non-formulary
 
   
Disodium edetate 0.37% eye drops
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for collagenase inhibitor
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Non-formulary
 
   
Disodium edetate 0.37% solution
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved as chelating agent, aid to calcified corneal plaque removal  
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Non-formulary
 
   
FluorEscein injection
(Ocular dye for fluoroscopic angiography)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • 20% available
  • RFL:
    • Approve for ophthalmic angiography, e.g. examination of fundus and iris vasculature, sclera and episclera (10% & 20% available)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Glycerol eye drops
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for clearing corneal oedema (50% drops available)
  • RNOH: 
    • Non-formulary
  • UCLH:
  • WH:
    • This is unlicensed and restricted to Ophthalmology
 
   
Mydricaine
(Ophthalmic)
View childrens BNF
Unlicensed Drug Unlicensed

Provider notes

  • NMUH:
    • For rapid mydriasis and prevention of synechiae in uveitis.
    • Mydricaine No.1 and No.2 Injection, available from ‘special-order’ manufacturers or specialist importing companies
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • MYDRICAINE NO. 2 This is an unlicensed special and restricted to Ophthalmology.
    • MYDRICAINE NO.1 This is an unlicensed special and restricted to Ophthalmology.
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary